Keyphrases
Glioblastoma
100%
Temozolomide
50%
Imiquimod
50%
Organoids
50%
Topical Imiquimod
50%
Tumor Treatment
50%
Patient-derived
50%
Tumor Heterogeneity
50%
Treatment Sensitivity
50%
High-grade Cervical Intraepithelial Neoplasia
50%
Small Molecule Inhibitors
50%
Lessons Learned
50%
Glioblastoma Therapy
50%
Clinical Trials
50%
LLETZ
42%
Intratumoral Heterogeneity
24%
Resistance Mechanisms
21%
Genetic Heterogeneity
20%
Treatment Resistance
20%
JNK MAP Kinase
20%
Surgical Treatment
14%
Imiquimod Cream
14%
High-risk Human Papillomavirus (HR-HPV)
14%
Treatment Modalities
14%
New Drugs
14%
Intensive Care Medicine
14%
Specific Genes
14%
Treatment Response
10%
Differential Response
10%
Whole Exome Sequencing
10%
INIS
glioblastomas
100%
patients
75%
tumors
68%
zones
50%
sensitivity
50%
transformations
50%
organoids
50%
women
50%
molecules
50%
clinical trials
50%
drugs
45%
genetics
30%
surgery
22%
genes
22%
range
20%
karyotype
20%
kinases
20%
reviews
18%
comparative evaluations
18%
humans
16%
side effects
16%
clearance
16%
risks
16%
chemotherapy
12%
methylation
10%
retention
10%
promoters
10%
biology
10%
data
10%
variations
10%
